Table 4.
Performance of biochips in comparison with DST
| Biochip resulta |
Number of isolates with the indicated result |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OFX |
LVX |
MFX |
KAN |
CAPb |
XDR |
|||||||
| R | S | R | S | R | S | R | S | R | S | R | S | |
| R |
41 |
0 |
24 |
17 |
40 |
1 |
33 |
2 |
16 |
1 |
26 |
2 |
| S |
1 |
23 |
0 |
24 |
0 |
24 |
1 |
29 |
0 |
48 |
2 |
37 |
| Sensitivity (%) |
98 |
100 |
100 |
97 |
100 |
93 |
||||||
| Specificity (%) | 100 | 59 | 98 | 94 | 94 | 95 | ||||||
a - R, isolates with mutations in gyrA, gyrB (FQ), rrs(KAN and CAP), eis(KAN); S, isolates without mutations.
b - Isolates with mutations in eis were considered sensitive in biochip analysis.